Seeking Alpha

The FDA wants "additional preclinical safety information" from Idenix Pharmaceuticals (IDIX)...

The FDA wants "additional preclinical safety information" from Idenix Pharmaceuticals (IDIX) regarding IDX20963. This will put "clinical trials on hold" as the company works up a response. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|